New LEQEMBI Companion™ program launched to expand helpful resources for patients throughout the treatment journey, including Nurse Educators who can provide patients with injection training, and an ...
Veterinarians often give penicillin to horses during surgery to prevent infection, but the speed of injection may influence how the horse’s cardiovascular system reacts. In a study of 29 horses under ...
Despite flat overall Q2 2025 sales, Keytruda's continued strong performance in oncology supports long-term bullish prospects for Merck. Read the latest analysis on the stock here.
The Government plans to buy more vaping devices to give to people attempting to quit smoking, Newstalk ZB can reveal. The devices - possibly in the thousan ...
Underpinning Fiji's HIV epidemic is a spiralling trend of drug use, unsafe sex, needle sharing and "bluetoothing". Otherwise known as "hotspotting", this latter term refers to a practice where an ...
Utah prosecutors pursue capital punishment for Tyler Robinson, charged with the Sept 10, 2025, murder of Charlie Kirk.
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that pharmaceutical-grade Niagen ...
Clinical Trials Arena on MSN
Trials to watch: Three major catalysts in Alzheimer’s disease
While Lilly and Eisai/Biogen validated the amyloid theory in Alzheimer's disease, there are several trials of drugs with alternative MoAs.
More men are now living long enough to develop osteoporosis. But few are aware of the risk, and fewer still are screened and treated.
More patients receive hospital-level care at home with expansion of MOH’s hospital-to-home programme
NUHS' home-based care programme has cared for nearly 7,000 patients and saved over 42,000 hospital bed days. Read more at straitstimes.com. Read more at straitstimes.com.
IV Solution and Ketamine Centers of Chicago continues to demonstrate the transformative impact of its specialized mental health treatments through documented patient outcomes shared across multiple ...
Halozyme Therapeutics said on Wednesday it has agreed to acquire privately held Elektrofi in a deal worth up to $900 million to expand its drug delivery portfolio, sending its shares up 3% in morning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results